Granulation lines for research and development, takes the process from dispensed raw materials to finished tablet. Our systems clearly demonstrates the flexibility that can be achieved throughout the process – including high shear granulation, pelletizing and blending, etc.
All technologies can be brought together in an integrated process system that mimics the hundreds of large-scale plants provided by GEA globally. It epitomizes the approach of ensuring customers receive the same technology from the laboratory through to production, using the same containment and process technologies to ensure seamless scale-up and the most flexible blend of process capabilities.
Showing 4 of 8
Committed to providing flexible, modular equipment to support research and development in the pharmaceutical industry, the multipurpose AirConnect from GEA delivers a range of fluid bed processing solutions for small-scale applications.
The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.
An indispensable part of the ConsiGma 4.0 portfolio, the Conductor 4.0 control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
Designed to achieve optimal blending results, the ConsiGma® DB modules facilitate the testing of dosing and blending operations and can be integrated with any continuous up- or downstream process.
Every drop and every kilowatt hour count when it comes to centrifuge development.
GEA has been building centrifuges for over 130 years – something you wouldn’t think is in question every day. Jürgen Mackel, Vice President...
Through investments in renewable energy, GEA is lowering its CO2 emissions around the world.
When it comes to improving the health of the planet, GEA takes a leading role. As one of our sustainability-focused strategic objectives, we are forging a path to help our customers across myriad industries to reduce energy use...